Controlled substances.
Summary
Existing law, the California Uniform Controlled Substances Act (the act) , classifies controlled substances into 5 designated schedules, with the most restrictive limitations generally placed on controlled substances classified in Schedule I, and the least restrictive limitations generally placed on controlled substances classified in Schedule V. The act restricts the prescription, furnishing, possession, sale, and use of controlled substances, and makes a violation of those laws a crime, except as specified. Existing law also defines drug paraphernalia and prohibits, among other things, the manufacture, sale, and possession, as specified, of drug paraphernalia. Existing law excludes from these prohibitions any testing equipment that is designed, marketed, used, or intended to be used to analyze a substance for the presence of fentanyl, ketamine, gamma hydroxybutyric acid, or any analog of fentanyl. This bill would add xylazine, as specified, to Schedule III of the act, except in certain circumstances relating to veterinary use, only after xylazine is placed on Schedule III of the federal Controlled Substances Act. The bill would also exclude from the prohibitions on paraphernalia any testing equipment to analyze a substance for the presence of xylazine and other emerging adulterants as determined by the State Department of Public Health. By creating a new crime, the bill would establish a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.
Bill status
passed
3 of 5 stages cleared
Introduction
Feb 2024
Committee Review
Aug 2024
Assembly Passage
May 2024
Senate Passage
Governor
Introduced Feb 16, 2024
Last action Aug 15, 2024
Floor votes · Assembly May 23, 2024
How they voted
73–0
Passed · 7 other
Total votes 80
May 23, 2024
D
Democratic62
93% Yea
R
Republican18
83% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
20
Key actions
7
Committee
8
Amendments
6
Aug 15, 2024
Upper · Passed
In committee: Held under submission.
upper
Aug 5, 2024
Committee
In committee: Referred to APPR suspense file.
upper
Jul 3, 2024
Upper · Passed
Read second time and amended. Re-referred to Com. on APPR.
upper
Jul 2, 2024
Introduced
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 5. Noes 0.) (July 2).
upper
Jun 5, 2024
Committee
Referred to Com. on PUB S.
upper
May 23, 2024
Lower · Passed
Read third time. Passed. Ordered to the Senate. (Ayes 73. Noes 0. Page 5611.)
lower
May 16, 2024
Lower · Passed
Read second time and amended. Ordered returned to second reading.
lower
May 16, 2024
Introduced
From committee: Amend, and do pass as amended. (Ayes 11. Noes 0.) (May 16).
lower
May 1, 2024
Committee
In committee: Set, first hearing. Referred to APPR. suspense file.
lower
Apr 23, 2024
Lower · Passed
From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 17. Noes 0.) (April 23). Re-referred to Com. on APPR.
lower
Apr 15, 2024
Committee
Re-referred to Com. on B. & P.
lower
Apr 11, 2024
Lower · Passed
Read second time and amended.
lower
Apr 10, 2024
Introduced
From committee: Amend, and do pass as amended and re-refer to Com. on B. & P. with recommendation: To Consent Calendar. (Ayes 8. Noes 0.) (April 2).
lower
Mar 11, 2024
Committee
Referred to Coms. on PUB. S. and B. & P.
lower
Feb 17, 2024
Lower · Passed
From printer. May be heard in committee March 18.
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Jasmeet Bains
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about AB 3029
Scope: CA
Hi! I can help you understand AB 3029. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline